Backed by AstraZeneca and Teradyne, the robotics company is betting that the next breakthrough in medicine will need a breakthrough on the factory floor.
Artificial intelligence can help design a promising medicine. It cannot deliver a dose by admiring its own calculations.…
NVIDIA’s blockbuster fiscal Q2 2027 earnings reinforced its position at the center of the global AI infrastructure boom. With record data-center revenue, accelerating demand for Blackwell and Vera Rubin systems, and a rising sovereign-AI opportunity, NVIDIA (NASDAQ: NVDA) is expanding from GPU…
The next major AI trade may not fit inside a data center. It may wear a pair of mechanical hands, work a night shift, and become one of the most consequential buyers of chips, sensors, software and industrial equipment of the decade.…
